Minute Insight: AbbVie Bets Big On Glaucoma Market With iSTAR Purchase Deal
Executive Summary
The pharmaceutical company has made a bold play to expand its presence in the device space, giving iSTAR upfront cash in a deal that grants it the right to buy iSTAR for almost half a billion dollars.